CASP1 and breast cancer: To assess the impact of the inflammasome on mammary cancer progression in vivo, MMTV-NeuV664E mice were bred with Caspase-1 knock-out (KO) mice, the main inflammasome effector, and the number of tumor-free mice was monitored over time.